English | Español

Merck & Company, Inc.
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Press release submission | Sep 23, 2019

MERCK: New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care

Trending
+ Pharmaceuticals
Patient Daily | Nov 21, 2024

Las Olas Wine & Food Festival set for April; ticket sales begin Black Friday
+ Pharmaceuticals
Patient Daily | Nov 15, 2024

Charlotte event raises $110k for lung cancer fight
+ Community
Patient Daily | Nov 19, 2024

Babylon Dental Care Associate Dentist Absatz: ‘Older adults should follow the same dental care guidelines as anyone else’
+ Pharmaceuticals
Patient Daily | Nov 19, 2024

Surgeon General's new report targets persistent health disparities linked to tobacco